Showing results (191-200 of 294) with videos related to
Sort By:
Pageof 30
Cytokine|January 8, 2017
Serum levels of fibroblast growth factor 23 are elevated in patients with active Lupus nephritisAline L Resende, Rosilene M Elias, Myles Wolf, et al.Kidney International|August 2, 2021
Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney diseaseRupal C Mehta, Monique E Cho, Xuan Cai, et al.Clinical Journal of the American Society of Nephrology : CJASN|July 15, 2017
Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney DiseaseMichel Chonchol, Berenice Gitomer, Tamara Isakova, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|April 22, 2017
Klotho, an antiaging molecule, attenuates oxidant-induced alveolar epithelial cell mtDNA damage and apoptosisSeok-Jo Kim, Paul Cheresh, Mesut Eren, et al.British Journal of Pharmacology|June 20, 2020
Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxisJoan Perelló, Miquel D Ferrer, Maria Del Mar Pérez, et al.Journal of Bone and Mineral Metabolism|December 13, 2016
Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestryDominique Kosk, Holly Kramer, Amy Luke, et al.Bone Research|May 3, 2019
DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney diseaseCorey Dussold, Claire Gerber, Samantha White, et al.Scientific Reports|May 18, 2017
FGF23/FGFR4-mediated left ventricular hypertrophy is reversibleAlexander Grabner, Karla Schramm, Neerupma Silswal, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 26, 2019
Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKDDaniel Edmonston, Daniel Wojdyla, Rupal Mehta, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 19, 2014
Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort studyPatrick H Pun, Anne S Hellkamp, Gillian D Sanders, et al.Pageof 30